Share
662 Posts.
lightbulb Created with Sketch. 90
clock Created with Sketch. 25/03/23
18:30
Share
Originally posted by kpt3891:
↑
Impedimed is so ahead of the game in the space, in particular the PREVENT 3 year trial should give IPD technology so much more credence in the eyes of health professionals. The NCCN guidelines are really the icing on the cake in terms of private payor $$$ coverage... mentioning of "bioimpedance spectroscopy " and regular screening is truly the JACKPOT for IPD who have ticked all the long and painful boxes to get to this point.
Expand
Yes, I think you are right about the first point. In fact, the wording was much more positive than I expected. As to a takeover, let's hope that management does not shortchange us.
